Substance Abuse, Intravenous
"Substance Abuse, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abuse, overuse, or misuse of a substance by its injection into a vein.
Below are MeSH descriptors whose meaning is more general than "Substance Abuse, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Substance Abuse, Intravenous".
This graph shows the total number of publications written about "Substance Abuse, Intravenous" by people in Harvard Catalyst Profiles by year, and whether "Substance Abuse, Intravenous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 7 | 11 |
1995 | 2 | 4 | 6 |
1996 | 2 | 7 | 9 |
1997 | 1 | 3 | 4 |
1998 | 7 | 4 | 11 |
1999 | 2 | 3 | 5 |
2000 | 2 | 2 | 4 |
2001 | 8 | 3 | 11 |
2002 | 3 | 4 | 7 |
2003 | 1 | 2 | 3 |
2004 | 2 | 2 | 4 |
2005 | 3 | 3 | 6 |
2006 | 6 | 6 | 12 |
2007 | 8 | 6 | 14 |
2008 | 4 | 4 | 8 |
2009 | 5 | 5 | 10 |
2010 | 9 | 4 | 13 |
2011 | 2 | 1 | 3 |
2012 | 9 | 3 | 12 |
2013 | 12 | 3 | 15 |
2014 | 12 | 1 | 13 |
2015 | 7 | 6 | 13 |
2016 | 13 | 7 | 20 |
2017 | 9 | 4 | 13 |
2018 | 12 | 3 | 15 |
2019 | 17 | 6 | 23 |
2020 | 19 | 4 | 23 |
2021 | 16 | 2 | 18 |
2022 | 15 | 0 | 15 |
2023 | 18 | 0 | 18 |
2024 | 4 | 0 | 4 |
Below are the most recent publications written about "Substance Abuse, Intravenous" by people in Profiles.
-
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. Lancet HIV. 2024 Feb; 11(2):e106-e116.
-
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019. Int J Drug Policy. 2024 Feb; 124:104311.
-
Comparison of Empirically Derived and Model-Based Estimates of Key Population HIV Incidence and the Distribution of New Infections by Population Group in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2024 01 01; 95(1S):e46-e58.
-
Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic Models. J Acquir Immune Defic Syndr. 2024 01 01; 95(1S):e59-e69.
-
Harm reduction stories: leveraging graphic medicine to engage veterans in substance use services within the VA. Harm Reduct J. 2023 Dec 06; 20(1):177.
-
Authors' Reply: Trend Analysis Shows There May Be Other Drivers Of The Endocarditis Epidemic in Addition to Intravenous Drug Use. Am J Cardiol. 2024 Jan 15; 211:380.
-
Overall, Direct, Spillover, and Composite Effects of Components of a Peer-Driven Intervention Package on Injection Risk Behavior Among People Who Inject Drugs in the HPTN 037 Study. AIDS Behav. 2024 Jan; 28(1):225-237.
-
Utility of self-report antiretroviral adherence for predicting HIV viral load among persons who inject drugs in Hai Phong Vietnam: assessing differences by methamphetamine use. AIDS Care. 2024 Apr; 36(4):553-560.
-
Shame and stigma in association with the HCV cascade to cure among people who inject drugs. Drug Alcohol Depend. 2023 Dec 01; 253:111013.
-
The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014. PLoS One. 2023; 18(8):e0290113.